Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.0150
-0.0450 (-2.18%)
NASDAQ· Last Trade: Jul 16th, 1:15 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors